SD
Shreekant Dattathray Sawant
About Shreekant Dattathray Sawant
Data last updated:
Shreekant Dattathray Sawant is a Managing Director at Centaur Pharmaceuticals Private Limited (since 2008) and Designated Partner at Minesfield Advisory Services Llp (since 2015). The companies operate in Pharma, Business Outsourcing and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹1,062 Cr; the largest is Centaur Pharmaceuticals Private Limited at ₹1,060 Cr (FY 2025). Earlier, Shreekant Dattathray Sawant was a Director at Chiron Realty Private Limited (2013–2014) and Director at Chikhloli Morivli Effluent Treatment (1996–2012) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Aug 2008 | 1980 | ₹1,060 Cr (FY 2025) | Active | |
| Designated Partner | 22 Dec 2015 | 2015 | ₹1.54 Cr (FY 2017) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Apr 2013 | 2013 | Amalgamated | ||
| Director | 22 May 1996 | 1994 | ₹1.90 Cr (FY 2025) | Active | |
| Director | 29 Jul 1983 | 1981 | Amalgamated | ||
| Director | 09 Jun 2015 | 2013 | ₹4 Lakh (FY 2015) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shreekant Dattathray Sawant
| Name | DIN | Company | Designation |
|---|---|---|---|
| Albert Tauro | 01860786 | Centaur Pharmaceuticals Private Limited | Director |
| Pritam Maruti Khawale | Centaur Pharmaceuticals Private Limited | Company Secretary | |
| Rakhi Shridhar Kadam | 02898330 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
| Sharadchandra Damodar Abhyankar | 00108866 | Centaur Pharmaceuticals Private Limited | Director |
| Shivanand Dattatray Sawant | 00407965 | Centaur Pharmaceuticals Private Limited , Minesfield Advisory Services Llp | Managing Director |
| Smita Abhayakumar Phal | 02887382 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
| Supriya Samar Desai | 07499177 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreekant Dattathray Sawant
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreekant Dattathray Sawant
Shreekant Dattathray Sawant currently holds 2 directorships: Centaur Pharmaceuticals Private Limited (Managing Director, since 01 Aug 2008, revenue ₹1,060 Cr (FY 2025)); Minesfield Advisory Services Llp (Designated Partner, since 22 Dec 2015, revenue ₹1.54 Cr (FY 2017)).
Shreekant Dattathray Sawant was first appointed on 29 Jul 1983 as Director at Centaur Chemicals Private Limited. The most recent appointment on record is 22 Dec 2015 at Minesfield Advisory Services Llp.
The 2 current companies of Shreekant Dattathray Sawant that report revenue have a combined latest revenue of ₹1,062 Cr: Centaur Pharmaceuticals Private Limited ₹1,060 Cr (FY 2025); Minesfield Advisory Services Llp ₹1.54 Cr (FY 2017).
Shreekant Dattathray Sawant held 4 earlier board appointments: Chiron Realty Private Limited (Director, 29 Apr 2013 to 21 Jan 2014); Chikhloli Morivli Effluent Treatment (Director, 22 May 1996 to 28 Feb 2012); Centaur Chemicals Private Limited (Director, from 29 Jul 1983); Minesfield Advisory Services Private Limited (Director, from 09 Jun 2015).
The current boards of Shreekant Dattathray Sawant's companies include Albert Tauro (Centaur Pharmaceuticals Private Limited), Pritam Maruti Khawale (Centaur Pharmaceuticals Private Limited), Rakhi Shridhar Kadam (Centaur Pharmaceuticals Private Limited), Sharadchandra Damodar Abhyankar (Centaur Pharmaceuticals Private Limited), Shivanand Dattatray Sawant (Centaur Pharmaceuticals Private Limited), Smita Abhayakumar Phal (Centaur Pharmaceuticals Private Limited), among others.